Peterson GG, Pu J, Magid DJ, et al. - This study sought to evaluate if the model increases the initiation or intensification of antihypertensive medications or statins among patients with blood pressure or low-density lipoprotein cholesterol levels above guideline thresholds for treatment intensification. Researchers examined patient outcomes for 1 year post enrollment (through December 2018) using an intent-to-treat design. The analysis enrolled a total of 330 primary care and cardiology practices, health care centers, and hospital-based outpatient departments and 125,436 Medicare patients. Despite high medication use at baseline, a pay-for-performance model led to modest increases in the use of cardiovascular Disease medications in a range of organizations.